Erin Hunter, Assistant Editor

The relationship between metabolic syndrome and some B vitamins, such as vitamin B12, was only observed among participants who took B12 supplements.

The stool-test is the first-of-its-kind to detect CRC in adults aged 45 to 49 years, with a premarket approval submission planned to be sent to the FDA early in 2023.

Soft tissue reconstruction solutions can leverage a patient’s natural healing response.

Research highlights that 6 doses of sublingual ketamine may be more effective than 3 doses, however both can ameliorate symptoms of anxiety and depression.

An app using AI to evaluate blood sugar data, concerning trends, and recommend management tools will be a part of a clinical trial in 2024 for further assessment.

Energy crisis in Europe puts strain on production and could have ramifications that extend beyond the continent's borders.

The head of the CAR T cell antibody can recognize and target the growth factor in its tumor microenvironment.

The atypical antipsychotic is an extended-release injectable suspension that is administered bi-weekly.

“It's an honor to walk the last steps with someone, it is.”-Mary Lynn McPherson, PharmD, MA, MDE, FAAHPM

Clostridium difficile is a gram-positive, spore-forming, bacterium that is mainly caused by recent hospitalizations, advanced age, or antibiotic treatments.

Viral infections can plague patients who have undergone stem cell transplantation.

Psilocybin is derived from certain types of mushrooms and has been proven to affect serotonin receptors.

The drug combination can significantly improve lung function and reduce severe asthma exacerbations.

The new CDC-approved app launched January 1, 2023.

In the geographical region of a recent study, data showed melanoma cause high mortality rates in relation to incidence.

Individuals in metropolitan counties used mental health services more than individuals in rural counties.

Black patients aged 18 to 49 years showed a greater association with uncontrolled blood pressure while on an antihypertensive medication.

If approved, glofitamab will treat the most aggressive type of non-Hodgkin lymphoma.

Relative risk calculations show that vaccinated individuals infected with the first Omicron subvariants of COVID-19 could have protection that lasts nearly 3 seasons.

Lecanemab (Lequembi) approved to treat mild cognitive impairment or mild dementia associated with Alzheimer disease.

This technology could facilitate equal access to value-based pathways in oncology care and optimize the individual treatment approach.

The novel antibody will receive expedited review, according to the FDA, and already has market authorization in the European Union.

The benefits of physical activity may be greater for children and adolescents with clinical depression or depressive symptoms, who may develop anxiety and other disorders in adulthood.

A study showed that the risk of developing venous thromboembolism is worse for perimenopausal women with diabetes.

Children who experienced COVID-19-induced multisystem inflammatory syndrome did not experience severe adverse reactions following COVID-19 vaccination.

The FDA granted fidanacogene elaparvovec breakthrough, regenerative medicines advance therapy, and orphan drug designations.

Products include the generic alternatives to Esbriet and Oracea.

But many patients pay more than necessary because of PBMs, patent abuses, IQVIA data shows.

An anti-cancer vaccine that is now in clinical trials shows promise as a preventative agent. However, experts are unsure when it will be widely available.

Lions and tigers and zebras oh my! Expert says precision medicine helps identify unique “zebras” (cancers), but it is increasingly difficult to keep up with new treatment indications across a broad range of cancers.